Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-008105

CEO and Chairman acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yu John S CEO and Chairman 2025-01-01 Grant or award +14,000 5,355,838 D
Loading xslF345X05/ownership.xml…